Inhaled Insulin Manufacturers Find Size Matters After Exubera Cmte. Review

Inhaled insulin manufacturers are emphasizing smaller devices and easier dosing of their products following the review of Pfizer/Sanofi-Aventis' Exubera by FDA's Endocrinologic & Metabolic Drugs Advisory Committee